Evidence map›Paper›PMID 36013520›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved.

Rasa Karaliūtė, Arnoldas Leleika, Ieva Apanavičiūtė, Tomas Kazakevičius, Vaida Mizarienė, Vytautas Zabiela, Aušra Kavoliūnienė, Nijolė Ragaišytė, Daiva Urbonienė, Gintarė Šakalytė

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rasa KaraliūtėLaboratory of Behavioural Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Arnoldas LeleikaKaunas Region Society of Cardiology, 50009 Kaunas, Lithuania.ORCID 0000-0003-2271-2431
Ieva ApanavičiūtėMedicine Faculty, Medicine Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Tomas KazakevičiusDepartment of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Vaida MizarienėDepartment of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Vytautas ZabielaDepartment of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Aušra KavoliūnienėDepartment of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Nijolė RagaišytėDepartment of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Daiva UrbonienėDepartment of Laboratory Medicine, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Gintarė ŠakalytėDepartment of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator reflecting fibrosis, is associated with laboratory indicators affecting the development of fibrosis, interleukin 6 (IL-6) or tumor necrosis factor α (TNF-α). Materials and Methods: The study included 92 persistent AF patients who underwent elective ECV. The effective maintenance of SR was evaluated after 40 ± 10 days of ECV. Echocardiography, inflammatory markers (high-sensitivity c-reactive protein (hs-CRP), IL-6, and TNF-α), and natriuretic peptides (N-terminal pro b-type natriuretic peptide (NT-proBNP) and N-terminal pro a-type natriuretic peptide (NT-proANP)) were assessed. Results: After a 40 ± 10 days observation period, 51 patients (55.4%) were in SR. Patients with AF recurrence had a significantly longer duration of AF (p = 0.008) and of arterial hypertension (p = 0.035), lower LA ejection fraction (p = 0.009), lower LA strain (p < 0.0001), higher left ventricular global longitudinal strain (p = 0.001), and a higher E/e‘ ratio (p < 0.0001). LA strain was an independent predictor of early AF recurrence (OR: 0.65; 95% Cl 0.5−0.9, p = 0.004). LA strain < 11.85% predicted AF recurrence with 70% sensitivity and 88% specificity (AUC 0.855, 95% CI 0.77−0.94, p < 0.0001). LA strain demonstrated the association with NT-proBNP (r = −0.489, p < 0.0001) and NT-proANP (r = −0.378, p = 0.002), as well as with hs-CRP (r = −0.243, p = 0.04). Conclusions: LA strain appeared to be the most accurate predictor of early AF recurrence after ECV in patients with persistent AF. LA strain inversely correlated with NT-proBNP and NT-proANP, but no significant association with any of the inflammatory markers was identified.

Indexed as

Atrial FibrillationElectric CountershockBiomarkersC-Reactive ProteinFibrosisHumansInterleukin-6Natriuretic PeptidesRecurrenceRisk FactorsStroke VolumeTumor Necrosis Factor-alphaVentricular Function, LeftBiomarkersC-Reactive ProteinInterleukin-6Natriuretic PeptidesTumor Necrosis Factor-alphaatrial fibrillationbiomarkerscardioversionfibrosisinflammatoryleft atrial strainnatriuretic peptides

Identifiers

PMID36013520
PMCPMC9416115
OpenAlexW4289939657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.